日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PRMT6 is required for initiating and amplifying macrophage-induced inflammation in heterotopic ossification by increasing CCL2 expression

PRMT6通过增加CCL2表达,在异位骨化过程中启动和放大巨噬细胞诱导的炎症反应中发挥重要作用。

Chu, Wenxiang; Peng, Weilin; Wu, Zhengqiang; Xiong, Yu; Gao, Zhongya; Li, Yang; Zhang, Bangke; Wang, Liang; Wang, Haibin; Han, Chaofeng; Lu, Xuhua

Metformin Impairs Breast Cancer Growth through the Inhibition of PRMT6

二甲双胍通过抑制PRMT6来抑制乳腺癌生长

Wu, Yinsheng; Xu, Xinlin; Tong, Yue; Wang, Min; Ge, Feng; Wu, Min; Wang, Yunlong; Chen, Gang; Yu, Xilan; Li, Shanshan

Correction to 'Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor'

更正“PRMT6 的消融揭示了其作为 p53 肿瘤抑制因子的负转录调控因子的作用”

Hypoxia-induced PRMT6 expression promotes temozolomide chemoresistance in glioblastoma via G3BP1.

缺氧诱导的 PRMT6 表达通过 G3BP1 促进胶质母细胞瘤对替莫唑胺的化疗耐药性。

Chen Shuyang, Yu Peng, Sun Yongqing, Yan Yuting, Zhang Boxiang, Li Guangyu

Race and Sex Differences in PRMT6 Expression in Lung Tumors in Relation to Neighborhood Violence

种族和性别差异与肺癌中PRMT6表达及社区暴力之间的关系

Roberts, J Dontaé; Motley, Robert O Jr; Kim, Sage J; Mahmoud, Abeer M; Sverdlov, Maria; David, Odile; Winn, Robert A

Erratum: Author correction to "PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism" [Acta Pharm Sin B 13 (2023) 157-173]

勘误:作者更正“PRMT6 通过触发 6PGD/ENO1 介导的细胞代谢促进肺癌的致瘤性和顺铂反应”[Acta Pharm Sin B 13 (2023) 157-173]

Sun, Mingming; Li, Leilei; Niu, Yujia; Wang, Yingzhi; Yan, Qi; Xie, Fei; Qiao, Yaya; Song, Jiaqi; Sun, Huanran; Li, Zhen; Lai, Sizhen; Chang, Hongkai; Zhang, Han; Wang, Jiyan; Yang, Chenxin; Zhao, Huifang; Tan, Junzhen; Li, Yanping; Liu, Shuangping; Lu, Bin; Liu, Min; Kong, Guangyao; Zhao, Yujun; Zhang, Chunze; Lin, Shu-Hai; Luo, Cheng; Zhang, Shuai; Shan, Changliang

Methylation of RBM39 by PRMT6 enhances resistance to Indisulam in non-small cell lung cancer by promoting alternative splicing of proto-oncogenes

PRMT6 对 RBM39 的甲基化通过促进原癌基因的选择性剪接,增强非小细胞肺癌对 Indisulam 的耐药性。

Tongjia Zhang ,Shujie Wang ,Yue Zhou ,Zitao Jiao ,Kejia Lu ,Xinyi Liu ,Hui Li ,Wei Jiang ,Xiaowei Zhang

PRMT6 inhibitors promote fracture healing by modulating osteoclast glucose metabolism

PRMT6抑制剂通过调节破骨细胞葡萄糖代谢促进骨折愈合

Wu, Nan; Wang, Renkai; Nian, Shensheng; Zhang, Hao; Zhou, Panyu; Tang, Hao

ID3 promotes erythroid differentiation and is repressed by a TAL1-PRMT6 complex

ID3促进红系分化,并受TAL1-PRMT6复合物抑制。

Heller, Vivien; Wang, Lei; Schneider, Edith; Gerstner, Mirjam; Bajer, Luana; Decker, Robin; Boenig, Halvard; Lausen, Joern

Enhancement of PRMT6 binding to a novel germline GATA1 mutation associated with congenital anemia

PRMT6 与一种与先天性贫血相关的新型种系 GATA1 突变结合增强

Lu, Yingsi; Zhu, Qingqing; Wang, Yun; Luo, Meiling; Huang, Junbin; Liang, Qian; Huang, Lifen; Ouyang, Jing; Li, Chenxin; Tang, Nannan; Li, Yan; Kang, Tingting; Song, Yujia; Xu, Xiaoyu; Ye, Liping; Zheng, Guoxing; Chen, Chun; Zhu, Chengming